DOI QR코드

DOI QR Code

Cannabinoids in periodontal disease amid the COVID-19 pandemic

  • Park, Jun-Beom (Department of Periodontics, The Catholic University of Korea College of Medicine) ;
  • Jung, Kwang-Mook (Department of Anatomy and Neurobiology, University of California School of Medicine) ;
  • Piomelli, Daniele (Department of Anatomy and Neurobiology, University of California School of Medicine)
  • 투고 : 2020.11.24
  • 심사 : 2020.12.02
  • 발행 : 2020.12.31

초록

키워드

참고문헌

  1. Jung KM, Piomelli D. Cannabinoids and endocannabinoids. In: Pfaff DW, Volkow ND, editors. Neuroscience in the 21st century: from basic to clinical. New York (NY): Springer New York; 2016. p.1811-41.
  2. Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol 2020;16:9-29. https://doi.org/10.1038/s41582-019-0284-z
  3. Chisini LA, Cademartori MG, Francia A, Mederos M, Grazioli G, Conde MC, et al. Is the use of Cannabis associated with periodontitis? A systematic review and meta-analysis. J Periodontal Res 2019;54:311-7. https://doi.org/10.1111/jre.12639
  4. Shariff JA, Ahluwalia KP, Papapanou PN. Relationship between frequent recreational cannabis (marijuana and hashish) use and periodontitis in adults in the United States: National Health and Nutrition Examination Survey 2011 to 2012. J Periodontol 2017;88:273-80. https://doi.org/10.1902/jop.2016.160370
  5. Rawal SY, Tatakis DN, Tipton DA. Periodontal and oral manifestations of marijuana use. J Tenn Dent Assoc 2012;92:26-31.
  6. Xiong W, Cui T, Cheng K, Yang F, Chen SR, Willenbring D, et al. Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors. J Exp Med 2012;209:1121-34. https://doi.org/10.1084/jem.20120242
  7. Cuba LF, Salum FG, Guimaraes FS, Cherubini K, Borghetti RL, de Figueiredo MA. Cannabidiol on 5-FUinduced oral mucositis in mice. Oral Dis 2020;26:1483-93. https://doi.org/10.1111/odi.13413
  8. Zhang F, Ozdemir B, Nguyen PQ, Andrukhov O, Rausch-Fan X. Methanandamide diminish the Porphyromonas gingivalis lipopolysaccharide induced response in human periodontal ligament cells. BMC Oral Health 2020;20:107. https://doi.org/10.1186/s12903-020-01087-6
  9. Abidi AH, Presley CS, Dabbous M, Tipton DA, Mustafa SM, Moore BM 2nd. Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts. Arch Oral Biol 2018;87:79-85. https://doi.org/10.1016/j.archoralbio.2017.12.005
  10. Jager A, Setiawan M, Beins E, Schmidt-Wolf I, Konermann A. Analogous modulation of inflammatory responses by the endocannabinoid system in periodontal ligament cells and microglia. Head Face Med 2020;16:26. https://doi.org/10.1186/s13005-020-00244-0
  11. Abidi AH, Alghamdi SS, Dabbous MK, Tipton DA, Mustafa SM, Moore BM. Cannabinoid type-2 receptor agonist, inverse agonist, and anandamide regulation of inflammatory responses in IL-1β stimulated primary human periodontal ligament fibroblasts. J Periodontal Res 2020;55:762-83. https://doi.org/10.1111/jre.12765
  12. Bartel SJ, Sherry SB, Stewart SH. Self-isolation: a significant contributor to cannabis use during the COVID-19 pandemic. Subst Abus. Forthcoming 2020.
  13. Vidot DC, Islam JY, Marlene Camacho-Rivera , Harrell MB, Rao DR, Chavez JV, et al. The COVID-19 cannabis health study: results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States. J Addict Dis. Forthcoming 2020.